Latest News about Phase 1 Trial
Recent news which mentions Phase 1 Trial
   FDA Clears Lyell Immunopharma' LYL132 Trial For Solid Tumors
   
  
  
  January 24, 2022
  From Benzinga
 
   FDA Gives Nod To TScan Therapeutics' Early-Stage Trial Of TSC-100 In Hematologic Malignancies
   
  January 24, 2022
  Tickers 
   TCRX
  
  
  From Benzinga
 
   Masonic Cancer Center To Evaluate HCW Biologics' Bifunctional Fusion Protein In Advanced Cancers
   
  January 24, 2022
  Tickers 
   HCWB
  
  
  From Benzinga
 
   Regulus Therapeutics Moves Forward With Next-Gen Compound, RGLS8429 In Kidney Disorder
   
  January 21, 2022
  Tickers 
   RGLS
  
  
  From Benzinga
 
   FDA Lifts Partial Hold On Kura Oncology's Early-Stage Leukemia Trial
   
  January 21, 2022
  Tickers 
   KURA
  
  
  From Benzinga
 
   FDA Clears Turning Point's IND For Elzovantinib + Aumolertinib Combo Regime In Lung Cancer Setting
   
  
  
  January 20, 2022
  From Benzinga
 
   Seagen's SEA-CD40 Combo Regime Shows Preliminary Antitumor Activity In Pancreatic Cancer
   
  
  
  January 19, 2022
  From Benzinga
 
   Cardiff Oncology Slumps On New Data From Lead Program In Metastatic Colorectal Cancer
   
  January 19, 2022
  Tickers 
   CRDF
  
  
  From Benzinga
 
   Vaxcyte Raises $100M Via Equity To Fund Development Of Lead Pneumococcal Vaccine Candidate
   
  January 13, 2022
  Tickers 
   PCVX
  
  
  From Benzinga
 
   Galmed's Potential Ulcerative Colitis Candidate Shows Encouraging Action In Early Study
   
  January 10, 2022
  Tickers 
   GLMD
  
  
  From Benzinga
 
   Anavex Life's Neurodegenerative Disease Candidate Meets Primary Endpoint In Early-Stage Study
   
  January 10, 2022
  Tickers 
   AVXL
  
  
  From Benzinga
 
   Edgewise Therapeutics Shares Jump After Positive Data On Becker Muscular Dystrophy Study
   
  January 05, 2022
  Tickers 
   EWTX
  
  
  From Benzinga
 From Benzinga
 
   Mereo BioPharma's Alvelestat Shows Improvement In COVID-19 Severity
   
  December 22, 2021
  Tickers 
   MREO
  
  
  From Benzinga
 
   Alzamend Neuro Shares Are Trading Higher After Encourage Early-Stage Data From Alzheimer's Candidate
   
  December 17, 2021
  Tickers 
   ALZN
  
  
  From Benzinga
 
   UniQure Shares Fall After Clinical Update From Huntington's Disease Gene Therapy Trial
   
  December 16, 2021
  Tickers 
   QURE
  
  
  From Benzinga
 From Benzinga
 
   Aptose Shares Fall After HM43239 Data Featured At ASH Annual Meeting, Luxeptinib, APTO-253 Update
   
  December 14, 2021
  Tickers 
   APTO
  
  
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

